Bronte Capital Management Pty
Latest statistics and disclosures from Bronte Capital Management Pty's latest quarterly 13F-HR filing:
- Top 5 stock holdings are REGN, GOOGL, IBKR, Visa Inc-class A Shares, BRK.B, and represent 51.40% of Bronte Capital Management Pty's stock portfolio.
- Added to shares of these 10 stocks: DIS (+$17M), BF.B (+$12M), RVMD, IJR, TYL, TBBB, GLBE, RSKD, TMCI, ANTX.
- Started 15 new stock positions in ABOS, PACB, BF.B, ANTX, TMCI, CMRC, GOSS, SEER, PEPG, TYL. BLND, RVMD, ALXO, IJR, NBP.
- Reduced shares in these 10 stocks: IBKR (-$35M), GOOGL (-$27M), NKTR (-$14M), IWO (-$13M), Brown Forman Corp call (-$13M), HLF (-$8.1M), PINS (-$7.9M), PM (-$7.4M), Visa Inc-class A Shares (-$6.7M), REGN (-$6.3M).
- Sold out of its positions in IVVD, Brown Forman Corp call, CRBU, GUTS, IWO, JRVR, PINS, PLRX, RANI, SBH.
- Bronte Capital Management Pty was a net seller of stock by $-138M.
- Bronte Capital Management Pty has $931M in assets under management (AUM), dropping by -7.81%.
- Central Index Key (CIK): 0001471085
Tip: Access up to 7 years of quarterly data
Positions held by Bronte Capital Management Pty consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bronte Capital Management Pty
Bronte Capital Management Pty holds 56 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals (REGN) | 15.5 | $144M | -4% | 231k | 623.54 |
|
| Alphabet Cap Stk Cl A (GOOGL) | 11.7 | $109M | -20% | 305k | 357.37 |
|
| Interactive Brokers Group Com Cl A (IBKR) | 8.3 | $77M | -31% | 884k | 87.04 |
|
| Visa Inc-class A Shares | 8.1 | $76M | -8% | 220k | 343.09 |
|
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 7.8 | $73M | -5% | 146k | 500.39 |
|
| Amazon (AMZN) | 6.7 | $62M | -8% | 261k | 238.34 |
|
| Philip Morris International (PM) | 5.8 | $54M | -11% | 300k | 180.91 |
|
| Corteva (CTVA) | 4.2 | $39M | -9% | 457k | 84.69 |
|
| Capital One Financial (COF) | 3.7 | $35M | -7% | 174k | 200.62 |
|
| Walt Disney Company (DIS) | 3.7 | $35M | +94% | 360k | 96.25 |
|
| First Ctzns Bancshares Inc N Cl A (FCNCA) | 3.2 | $30M | -14% | 14k | 2080.79 |
|
| Bbb Foods Cl A Com (TBBB) | 2.4 | $22M | +9% | 533k | 41.67 |
|
| Aurora Innovation Class A Com (AUR) | 1.6 | $15M | -5% | 2.2M | 6.82 |
|
| Vaneck Etf Trust Gold Miners Etf | 1.6 | $15M | -7% | 192k | 75.45 |
|
| Sotera Health | 1.5 | $14M | -5% | 797k | 17.75 |
|
| Nektar Therapeutics Com New (NKTR) | 1.5 | $14M | -50% | 198k | 69.81 |
|
| Graham Hldgs Com Cl B (GHC) | 1.4 | $13M | -10% | 12k | 1141.42 |
|
| Ishares Tr Ishares Biotech (IBB) | 1.3 | $13M | -4% | 66k | 190.19 |
|
| Brown Forman Corp CL B (BF.B) | 1.3 | $12M | NEW | 464k | 26.65 |
|
| Alnylam Pharmaceuticals (ALNY) | 1.1 | $11M | -4% | 35k | 301.03 |
|
| Sociedad Quimica Y Minera De Spon Adr Ser B (SQM) | 0.9 | $8.6M | -4% | 116k | 74.04 |
|
| Global E Online SHS (GLBE) | 0.8 | $7.9M | +6% | 228k | 34.73 |
|
| Newmont Mining Corporation (NEM) | 0.7 | $6.5M | -7% | 70k | 93.40 |
|
| Barrick Mng Corp Com Shs (B) | 0.6 | $5.4M | -7% | 146k | 36.73 |
|
| Liveramp Holdings (RAMP) | 0.5 | $4.8M | -42% | 128k | 37.64 |
|
| Herbalife Nutrition Com Shs (HLF) | 0.5 | $4.3M | -65% | 323k | 13.15 |
|
| Revolution Medicines (RVMD) | 0.4 | $3.5M | NEW | 19k | 187.28 |
|
| Turning Pt Brands (TPB) | 0.4 | $3.5M | -4% | 41k | 84.81 |
|
| Ishares Tr Core S&p Scp Etf (IJR) | 0.4 | $3.4M | NEW | 23k | 148.31 |
|
| Bath & Body Works In (BBWI) | 0.4 | $3.3M | -7% | 144k | 23.13 |
|
| Mondelez Intl Cl A (MDLZ) | 0.3 | $3.1M | -4% | 53k | 57.84 |
|
| Riskified Shs Cl A (RSKD) | 0.3 | $3.0M | +20% | 588k | 5.04 |
|
| Brown Forman Corp Cl A (BF.A) | 0.3 | $2.6M | -4% | 95k | 27.36 |
|
| Tyler Technologies (TYL) | 0.3 | $2.4M | NEW | 8.3k | 292.46 |
|
| Vaneck Etf Trust Junior Gold Mine | 0.3 | $2.4M | -7% | 25k | 98.25 |
|
| Paylocity Holding Corporation (PCTY) | 0.2 | $1.9M | -51% | 18k | 104.53 |
|
| Nice Sponsored Adr (NICE) | 0.2 | $1.5M | -4% | 16k | 90.85 |
|
| Universal Display Corporation (OLED) | 0.1 | $889k | -7% | 10k | 86.59 |
|
| Verisk Analytics (VRSK) | 0.1 | $482k | -7% | 2.7k | 179.53 |
|
| Treace Med Concepts (TMCI) | 0.0 | $62k | NEW | 16k | 3.98 |
|
| Fate Therapeutics (FATE) | 0.0 | $59k | -4% | 22k | 2.70 |
|
| An2 Therapeutics (ANTX) | 0.0 | $53k | NEW | 11k | 4.84 |
|
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $48k | +3% | 10k | 4.67 |
|
| Alx Oncology Hldgs (ALXO) | 0.0 | $38k | NEW | 18k | 2.07 |
|
| Blend Labs Cl A (BLND) | 0.0 | $33k | NEW | 19k | 1.71 |
|
| Pepgen (PEPG) | 0.0 | $32k | NEW | 18k | 1.80 |
|
| Enovix Corp (ENVX) | 0.0 | $32k | +261% | 42k | 0.75 |
|
| Commerce.com Com Ser 1 (CMRC) | 0.0 | $30k | NEW | 10k | 2.96 |
|
| Pacific Biosciences of California (PACB) | 0.0 | $30k | NEW | 18k | 1.68 |
|
| Acumen Pharmaceuticals (ABOS) | 0.0 | $29k | NEW | 11k | 2.67 |
|
| Seer Com Cl A (SEER) | 0.0 | $25k | NEW | 15k | 1.66 |
|
| Alector (ALEC) | 0.0 | $24k | -39% | 12k | 2.01 |
|
| Novabridge Biosciences Sponsored Ads (NBP) | 0.0 | $22k | NEW | 11k | 1.95 |
|
| Coherus Biosciences (CHRS) | 0.0 | $21k | -20% | 15k | 1.40 |
|
| Milestone Pharmaceuticals (MIST) | 0.0 | $19k | +38% | 14k | 1.34 |
|
| Gossamer Bio (GOSS) | 0.0 | $11k | NEW | 68k | 0.16 |
|
Past Filings by Bronte Capital Management Pty
SEC 13F filings are viewable for Bronte Capital Management Pty going back to 2018
- Bronte Capital Management Pty 2026 Q2 filed Aug. 5, 2026
- Bronte Capital Management Pty 2026 Q1 filed April 27, 2026
- Bronte Capital Management Pty 2025 Q4 filed Feb. 3, 2026
- Bronte Capital Management Pty 2025 Q3 filed Nov. 5, 2025
- Bronte Capital Management Pty 2025 Q2 filed Aug. 12, 2025
- Bronte Capital Management Pty 2025 Q1 filed May 14, 2025
- Bronte Capital Management Pty 2024 Q4 filed Feb. 10, 2025
- Bronte Capital Management Pty 2024 Q3 filed Nov. 5, 2024
- Bronte Capital Management Pty 2024 Q2 filed Aug. 7, 2024
- Bronte Capital Management Pty 2024 Q1 filed May 13, 2024
- Bronte Capital Management Pty 2023 Q4 filed Feb. 7, 2024
- Bronte Capital Management Pty 2023 Q3 filed Nov. 6, 2023
- Bronte Capital Management Pty 2023 Q2 filed Aug. 8, 2023
- Bronte Capital Management Pty 2023 Q1 filed May 12, 2023
- Bronte Capital Management Pty 2022 Q4 filed Feb. 14, 2023
- Bronte Capital Management Pty 2022 Q3 filed Nov. 3, 2022